Smith & Nephew Plc

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:03 2024-04-26 am EDT			5-day change	1st Jan Change
981 ^GBX	+1.72%		+2.00%	-9.04%

Apr. 11	UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates	MT
Apr. 11	Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal	MT

Smith & Nephew prices USD1 billion in debt notes

March 14, 2024 at 07:54 am EDT

Smith & Nephew PLC - Watford, England-based medical devices maker - Prices USD350.0 million in 3-year debt notes due 2027 with 5.15% coupon and USD650.0 million in 10-year notes due 2034 with 5.40% coupon. S&N says the net proceeds of USD990.6 million will be used to redeem outstanding private placement notes with coupons ranging from 3.26% to 3.89%, as well as for general corporate purposes. The new debt offer is expected to close on Wednesday next week.

Current stock price: 1,085.00 pence

12-month change: down 9.4%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Latest news about Smith & Nephew Plc

UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates	Apr. 11	MT
Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal	Apr. 11	MT
Smith+Nephew, Navbit Sign Distribution Deal for Hip Replacement Surgical Navigation System in Australia	Apr. 09	MT
Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing	Apr. 04	MT
Miach Orthopaedics Inc. announced that it has received $50 million in funding from a group of investors	Apr. 01	CI
Smith+Nephew Introduces the RENASYS EDGE Negative Pressure Wound Therapy System	Apr. 01	CI
London stocks round off March quarter with healthy gains	Mar. 28	RE
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	Mar. 28	MT
Smith & Nephew CFO designate John Rogers to start next week	Mar. 28	AN
Smith & Nephew CFO to Take Office in April	Mar. 28	MT
Smith & Nephew plc Announces CFO Changes	Mar. 28	CI
Smith & Nephew plc Announces Board Changes	Mar. 28	CI
Smith & Nephew Signs Up as Official Partner for UFC	Mar. 25	MT
Smith+Nephew Teams Up with Ufc to Be First-Ever Preferred Sports Medicine Technology Partner	Mar. 25	CI
Smith & Nephew prices USD1 billion in debt notes	Mar. 14	AN
Smith & Nephew plc Completes the Pricing of Usd 350,000,000 5.150% Notes Due 2027 and Usd 650,000,000 5.400% Notes Due 2034	Mar. 14	CI
Smith & Nephew Prices Offering of Notes due 2027, 2034	Mar. 14	MT
UK's Smith & Nephew Mulls Raising Pay for US Execs	Mar. 12	MT
Jefferies says buy BP; UBS says buy Compass	Mar. 04	AN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23	Feb. 29
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Feb. 28	MT
Smith & Nephew Signs Research Deal With US Army Institute of Surgical Research	Feb. 28	MT
Barclays Lifts Smith & Nephew PT, Maintains Equalweight Rating	Feb. 28	MT
Berenberg, JPMorgan raise price target for IHG	Feb. 28	AN

Chart Smith & Nephew Plc

Duration

Period

More charts

Company Profile

Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-01 - Q1 2024 Sales and Revenue Release - Trading Update

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23

February 29, 2024 at 07:52 am EST

More Strategies

Ratings for Smith & Nephew Plc

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.22 USD

Average target price

16.41 USD

Spread / Average Target

+34.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
SMITH & NEPHEW PLC	-9.04%	10.65B
STRYKER CORPORATION	+12.07%	128B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B
DOUBLE MEDICAL TECHNOLOGY INC.	-22.81%	1.79B

Medical Devices & Implants